Macrogenics Inc (MGNX)
15.61
-0.47
(-2.92%)
USD |
NASDAQ |
Apr 19, 16:00
15.61
0.00 (0.00%)
After-Hours: 20:00
Macrogenics Total Liabilities (Quarterly): 145.80M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 145.80M |
September 30, 2023 | 145.99M |
June 30, 2023 | 134.11M |
March 31, 2023 | 234.23M |
December 31, 2022 | 138.46M |
September 30, 2022 | 72.39M |
June 30, 2022 | 75.56M |
March 31, 2022 | 93.23M |
December 31, 2021 | 95.63M |
September 30, 2021 | 100.72M |
June 30, 2021 | 106.87M |
March 31, 2021 | 84.91M |
December 31, 2020 | 82.86M |
September 30, 2020 | 82.80M |
June 30, 2020 | 79.81M |
March 31, 2020 | 74.84M |
December 31, 2019 | 81.87M |
September 30, 2019 | 96.25M |
June 30, 2019 | 89.23M |
March 31, 2019 | 94.02M |
December 31, 2018 | 89.25M |
September 30, 2018 | 72.71M |
Date | Value |
---|---|
June 30, 2018 | 74.86M |
March 31, 2018 | 78.80M |
December 31, 2017 | 74.64M |
September 30, 2017 | 52.38M |
June 30, 2017 | 43.50M |
March 31, 2017 | 40.08M |
December 31, 2016 | 42.51M |
September 30, 2016 | 39.76M |
June 30, 2016 | 38.87M |
March 31, 2016 | 39.40M |
December 31, 2015 | 45.93M |
September 30, 2015 | 44.76M |
June 30, 2015 | 42.51M |
March 31, 2015 | 47.08M |
December 31, 2014 | 52.60M |
September 30, 2014 | 54.54M |
June 30, 2014 | 63.74M |
March 31, 2014 | 56.95M |
December 31, 2013 | 46.87M |
September 30, 2013 | 46.02M |
June 30, 2013 | 53.11M |
December 31, 2012 | 61.98M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
72.39M
Minimum
Sep 2022
234.23M
Maximum
Mar 2023
106.08M
Average
93.23M
Median
Mar 2022
Total Liabilities (Quarterly) Benchmarks
Allurion Technologies Inc | 142.20M |
United Therapeutics Corp | 1.182B |
MEI Pharma Inc | 19.05M |
Marinus Pharmaceuticals Inc | 154.14M |
Voyager Therapeutics Inc | 114.96M |
Total Liabilities (Quarterly) Related Metrics
Total Assets (Quarterly) | 298.42M |
Shareholders Equity (Quarterly) | 152.61M |
Current Ratio | 4.480 |